Physician Assistant · Los Angeles, CA
NPI
1174755763
Since 2009
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1441 Eastlake Ave Ste 3444
Los Angeles, CA, 90089
Phone (323) 865-3963
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
252 services
Medicare patients, 2024
133
Average age 74
Drug cost, 2024
$7.9M
922 prescriptions
Company payments, 2025
$1,120
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachelle C Olsen was code 99213 (office e&m - established), 162 times for 104 patients. In total Rachelle C Olsen billed 252 services in 5 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 162 | 104 | $44.09 | $7,143 |
| 99214 Office E&M - Established | Facility | 76 | 44 | $67.05 | $5,096 |
By year: 2022 $6,660 for 132 services; 2023 $8,555 for 169 services; 2024 $13K for 252 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachelle C Olsen prescribed most often to Medicare patients was Xtandi (Enzalutamide), with 221 prescriptions and refills. In total Rachelle C Olsen wrote 922 Medicare prescriptions that cost $7.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xtandi Enzalutamide | 221 | 223 | 28 | $3.0M |
| Tagrisso Osimertinib Mesylate | 101 | 101 | 13 | $1.7M |
| Prednisone Generic | 43 | 51 | 19 | $176 |
| Levothyroxine Sodium Generic | 40 | 62 | Under 11 | $248 |
| Cabometyx Cabozantinib S-Malate | 38 | 38 | Under 11 | $930K |
| Abiraterone Acetate Generic | 24 | 24 | Under 11 | $6,867 |
| Rozlytrek Entrectinib | 19 | 19 | Under 11 | $386K |
| Erlotinib Hcl Generic | 18 | 18 | Under 11 | $13K |
| Mirtazapine Generic | 18 | 18 | Under 11 | $61.49 |
| Bicalutamide Generic | 17 | 17 | Under 11 | $256 |
| Clobetasol Propionate Generic | 16 | 17 | Under 11 | $1,693 |
| Nubeqa Darolutamide | 14 | 14 | Under 11 | $183K |
| Vitrakvi Larotrectinib Sulfate | 14 | 14 | Under 11 | $507K |
| Alecensa Alectinib Hcl | 13 | 13 | Under 11 | $218K |
| Triamcinolone Acetonide Generic | 13 | 15 | Under 11 | $87.94 |
Brand drugs: 527 claims; generic drugs: 395 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachelle C Olsen $1,120 ($1,120 in general payments such as food, travel and fees) from 14 companies. The largest payer was Janssen Biotech, Inc. with $315.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 3 | $315 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $150 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $125 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $125 |
| GlaxoSmithKline, LLC. GSK | 1 | $122 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $90.05 |
| Exelixis Inc. EXEL | 1 | $36.48 |
| Syndax Pharmaceuticals, Inc. SNDX | 1 | $31.71 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $27.77 |
| Genentech USA, Inc. ROG.SW | 1 | $24.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.